$27.51▼-0.30 (-1.08%)
Pre-Market:$27.51+0.00 (+0.00%)· 8:40 PM ET
Immunocore Holdings plc (IMCR)
R&D Expenses
$288.58M
TTM · Period ending: · USD

IMCR R&D Expenses
Latest reported$288.58Mperiod ending
Latest reported$288.58Mperiod ending
IMCR R&D Expenses ($6.54M → $288.58M)
Annual R&D Expenses
High-resolution chart · PNG
What is r&d expenses?
Research and development spending.
IMCR r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 274,869,000 | |
| 222,162,000 | |
| 129,422,036 | |
| 84,311,089 | |
| 74,311,436 | |
| 74,809,000 | |
| 99,991,000 | |
| 83,575,000 | |
| 61,157,038 | |
| 46,014,979 | |
| 22,125,068 | |
| 12,203,564 | |
| 6,538,123 |
Explore More
IMCR Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance